Invenire Partners, LP Inotiv, Inc. Transaction History
Invenire Partners, LP
- $65.3 Million
- Q3 2022
A detailed history of Invenire Partners, LP transactions in Inotiv, Inc. stock. As of the latest transaction made, Invenire Partners, LP holds 95,000 shares of NOTV stock, worth $197,600. This represents 100.0% of its overall portfolio holdings.
Number of Shares
95,000Holding current value
$197,600% of portfolio
100.0%Shares
1 transactions
Others Institutions Holding NOTV
# of Institutions
76Shares Held
8.14MCall Options Held
312KPut Options Held
136K-
Vanguard Group Inc Valley Forge, PA1.29MShares$2.69 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.27MShares$2.64 Million0.0% of portfolio
-
Kennedy Capital Management, Inc. St Louis, MO1MShares$2.09 Million0.06% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny353KShares$734,6100.0% of portfolio
-
Vantage Point Financial LLC Lisle, IL337KShares$700,0150.27% of portfolio
About Inotiv, Inc.
- Ticker NOTV
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 25,594,500
- Market Cap $53.2M
- Description
- Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segme...